Literature DB >> 2889765

Control of a Serratia marcescens outbreak in a maternity hospital.

D J Braver1, G J Hauser, L Berns, Y Siegman-Igra, B Muhlbauer.   

Abstract

During the period between October 1984 and January 1985, an outbreak of Serratia marcescens took place in the Serlin Maternity Hospital in Tel-Aviv. Four major and six minor infections were noted in newborn and preterm infants. An additional group of 24 neonates were asymptomatic carriers of S. marcescens. Extensive control measures were undertaken, including closing the SCBU to further admissions and the opening of a new SCBU. Other measures included maintaining babies in cohort groups, strict handwashing, and use of gloves and gowns. There was also intensified encouragement of breast feeding and thorough cleansing and disinfection of the SCBU and nurseries. After 3 months, the outbreak was controlled. No identified source for the outbreak was detected. We feel that the extensive measures employed were responsible for controlling the outbreak within a relatively short time.

Entities:  

Mesh:

Year:  1987        PMID: 2889765     DOI: 10.1016/0195-6701(87)90138-1

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Use of molecular typing to study the epidemiology of Serratia marcescens.

Authors:  A McGeer; D E Low; J Penner; J Ng; C Goldman; A E Simor
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 2.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Management and investigation of a Serratia marcescens outbreak in a neonatal unit in Switzerland - the role of hand hygiene and whole genome sequencing.

Authors:  Walter Zingg; Isabelle Soulake; Damien Baud; Benedikt Huttner; Riccardo Pfister; Gesuele Renzi; Didier Pittet; Jacques Schrenzel; Patrice Francois
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-11       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.